(Updated - June 11, 2024 5:04 AM EDT)

Baird analyst Joel Beatty initiates coverage on Neurogene (NASDAQ: NGNE) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE